stanozolol has been researched along with Breast Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andò, S; Capparelli, C; Catalano, S; Chimento, A; Lanzino, M; Panza, S; Pezzi, V; Sirianni, R | 1 |
Daniel, F; Rao, DG; Tyrrell, CJ | 1 |
2 other study(ies) available for stanozolol and Breast Neoplasms
Article | Year |
---|---|
Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation.
Topics: Anabolic Agents; Androgens; Aromatase; Breast Neoplasms; Cell Proliferation; Cell Survival; Drug Synergism; Enzyme Induction; Estradiol; Estrogen Receptor alpha; Female; Genes, Reporter; Humans; Insulin-Like Growth Factor I; Luciferases, Renilla; MCF-7 Cells; Nandrolone; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Stanozolol; Type C Phospholipases; Up-Regulation | 2012 |
A pilot study of stanozolol for advanced breast carcinoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Humans; Lymphatic Metastasis; Megestrol; Megestrol Acetate; Middle Aged; Pilot Projects; Remission Induction; Stanozolol; Tamoxifen | 1991 |